Evidence map›Paper›PMID 40357229›Full record

ArticleFrontiers in aging neuroscience2025

Handgrip strength and risk of cognitive impairment across different glucose metabolism statuses: insights from the CHARLS study.

Shiqi Wang, Liangchen Li, Jia Yu, Xianli Sun, Jianqiao Chen

Abstract read
In one paragraph

Article in Frontiers in aging neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shiqi Wang *Department of General, Zhengzhou First People's Hospital, Zhengzhou, China.
Liangchen Li *Department of Traditional Chinese Medicine, Navy Qingdao Special Service Recuperation Center, Qingdao, China.
Jia YuHaikou Cadre's Sanitarium of Hainan Military Region, Haikou, Hainan, China.
Xianli SunDepartment of Health Medicine, Hainan Branch of General Hospital of Chinese PLA, Sanya, Hainan, China.
Jianqiao ChenDepartment of Geriatric, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, People's Hospital of Henan University, Zhengzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Both low handgrip strength (HGS) and abnormal glucose metabolism have been implicated in an increased risk of cognitive impairment. However, whether HGS interacts with glucose metabolism status to influence cognitive function remains unclear. This study explores the relationship between HGS and cognitive impairment risk among middle-aged and older Chinese adults and examines the potential modulation of this association by glucose metabolism status. Methods: Data from the China Health and Retirement Longitudinal Study (CHARLS) collected in 2011 and 2018 were analyzed, including 7,301 participants aged ≥ 45 years. Cognitive impairment was the primary outcome. Logistic regression and restricted cubic spline (RCS) analyses were applied to evaluate the association between HGS and cognitive impairment risk across different glucose metabolism statuses. Results: The study included 7,301 participants (mean age: 58.8 ± 8.9 years; 49.3% female). Over a 7-year follow-up, the mean cognitive function score declined from 12.05 ± 3.30 to 7.75 ± 5.70. After adjusting for confounders, logistic regression analyses indicated that higher HGS was significantly associated with a lower risk of cognitive impairment. Participants in the highest HGS quartile (Q4) had a significantly reduced odds of cognitive impairment compared to those in the lowest quartile (Q1) (odds ratio [OR]: 0.59, 95% confidence interval [CI]: 0.49-0.71; Conclusion: Higher HGS is significantly associated with a reduced risk of cognitive impairment among middle-aged and older individuals, irrespective of glucose metabolism status. These findings suggest that HGS assessment could be a valuable universal tool for evaluating cognitive impairment risk, regardless of metabolic conditions.

Indexed as

CHARLScognitive impairmentglucose metabolism statushandgrip strengthmiddle-aged and older

Identifiers

PMID40357229
PMCPMC12066481

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.